They demonstrated that the CD38 knockout NK cells exhibited a more prominent metabolic profile, which increased ADCC-mediated killing of CD38+ multiple myeloma cell lines and patient-derived samples [205,207]. The gene discussed is CD38; the disease is plasma cell myeloma.